Replimune REPL
NASDAQ REPL
$13.07 -0.38 (-2.83%)
At close: Oct 2, 2026 · 4:00 PM EDT

Replimune (REPL) Return on Assets [ROA] (2018 - 2026)

Updated

Replimune (REPL) reported Return on Assets [ROA] of -100.90% for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 45.90 percentage points from -55.00% a year earlier and down 6.79 percentage points from the prior quarter.

Analysis

Replimune (REPL) Return on Assets [ROA] (2018 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Replimune posted Return on Assets [ROA] of -71.17%, down 23.66 percentage points from FY2025.

  • Return on Assets [ROA] has declined for five consecutive fiscal years, with a five-year change of -50.62 percentage points (FY2021 to FY2026).
  • By fiscal year, Return on Assets [ROA] came in at -47.51% in FY2025 (-9.53 pp), -37.98% in FY2024 (-6.56 pp), -31.41% in FY2023 (-7.91 pp) and -23.51% in FY2022 (-2.96 pp).
  • The fiscal Q1 2027 figure ranks as the lowest quarterly Return on Assets [ROA] in data going back to fiscal Q1 2019.
  • Year over year, Return on Assets [ROA] has now declined in each of the last 19 quarters, with an average year-over-year change of -24.55 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Assets [ROA] in five years was fiscal Q2 2022 (a gain of 2.41 percentage points); the low point was fiscal Q4 2026 (a drop of 51.28 percentage points).
  • Per Business Quant data, the three fiscal quarters before Q1 2027 came in at -94.11% (Q4 2026), -86.95% (Q3 2026) and -72.13% (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Replimune 1.10 Bn 1.10 Bn - -100.90%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -100.90%
Mar 31, 2026 -94.11%
Dec 31, 2025 -86.95%
Sep 30, 2025 -72.13%
Jun 30, 2025 -55.00%
Mar 31, 2025 -42.83%
Dec 31, 2024 -41.43%
Sep 30, 2024 -41.24%
Jun 30, 2024 -43.03%
Mar 31, 2024 -42.29%
Dec 31, 2023 -38.34%
Sep 30, 2023 -34.05%
Jun 30, 2023 -29.04%
Mar 31, 2023 -26.31%
Dec 31, 2022 -28.15%
Sep 30, 2022 -32.79%
Jun 30, 2022 -28.87%
Mar 31, 2022 -24.92%
Dec 31, 2021 -21.88%
Sep 30, 2021 -19.27%
API Access

Replimune Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=REPL&period=max&api_key=YOUR_API_KEY